Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**HYLO NIGHT** is a preservative-free ophthalmic lubricant ointment marketed for night-time relief of dry-eye symptoms, including burning, irritation, itching, foreign-body sensation, and ocular dryness. The product contains white petrolatum and mineral oil, lanolin, and light mineral oil, with retinyl palmitate as an inactive ingredient. Applied to the eye before sleep, its viscous lipid-based ointment spreads across the ocular surface, supplements the tear-film lipid barrier, reduces evaporative moisture loss, and provides prolonged physical protection during the night. HYLO NIGHT was developed by Ursapharm and is marketed in the United States as OPTASE HYLO Night by Scope Eyecare.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on HYLO NIGHT.